NCT06420297Phase 3Terminated

OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Study sponsor: ACADIA Pharmaceuticals Inc. · ACAD

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-12-19Actual
Enrollment · participants168Actual
Source updated2026-08-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 160 participants (planned). After: 168 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: May 2029. After: 19 Dec 2025.

Recruitment status changed

Before: Enrolling by invitation. After: Terminated.

Check registry source